Skip to main content
Sinopharm Group Co. Ltd. logo

Sinopharm Group Co. Ltd. — Investor Relations & Filings

Ticker · 1099 ISIN · CNE100000FN7 LEI · 529900N54X78YH9JYK92 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,610 across all filing types
Latest filing 2024-03-12 Regulatory Filings
Country CN China
Listing HKEX 1099

About Sinopharm Group Co. Ltd.

http://www.sinopharmholding.com

Sinopharm Group Co. Ltd. is a major state-owned enterprise recognized as the largest pharmaceutical logistics provider in Asia and a leading distributor and retailer of healthcare products. The company's core business revolves around providing comprehensive medical supply chain services, encompassing the wholesale and retail distribution of pharmaceuticals, medical devices, and general healthcare products. Sinopharm serves a broad customer base, including hospitals, primary health service institutions, and retail pharmacies. Furthermore, the Group maintains an integrated ecosystem that extends beyond distribution into the manufacturing of pharmaceuticals and chemical reagents, medical services, and industry-finance integration, positioning it as a full-spectrum service provider in the healthcare sector.

Recent filings

Filing Released Lang Actions
ANNOUNCEMENT COMPLETION OF CHANGE OF REGISTERED ADDRESS
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of a change of the company's registered address. It references previous announcements and circulars but does not contain financial data, management discussion, voting results, or any detailed report content. The document is short (1840 characters) and serves as a formal notification of a corporate administrative update. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Board/Management Information since it does not discuss management changes. It is not a regulatory filing in the sense of compliance or officer certification but rather a general corporate announcement. Given the nature and length, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other categories.
2024-03-12 English
NOTICE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a notice announcing a forthcoming board meeting scheduled for 22 March 2024. The purpose of the meeting includes considering and approving the annual results for the year ended 31 December 2023 and the declaration of dividends. The document does not contain any financial data or results itself, but rather informs about the meeting where such results will be discussed and approved. The document length is short (1743 characters), and it is clearly a notice rather than a report. According to the classification rules, such a notice about a board meeting is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit into other specific categories like Annual Report or Earnings Release. It is not a report publication announcement since it does not mention the report being published or attached, only the meeting to consider it.
2024-03-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 29 February 2024. It details movements in authorised/registered share capital, issued shares, and confirms compliance with listing rules. There is no financial performance data, earnings information, or management discussion. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited regarding share capital and share movements. This fits the category of a Regulatory Filing (RNS) as it is a compliance document reporting share capital status and movements, not a financial report or announcement of voting results or capital changes per se. The document length (7148 characters) and content confirm it is a substantive regulatory filing rather than a brief announcement or report publication notice.
2024-03-04 English
Notification Letter and Reply Form to Non-Registered Shareholders-Arrangement of Electronic Dissemination of Corporate Communications
Report Publication Announcement Classification · 95% confidence The document is a letter dated 8 February 2024 from Sinopharm Group Co. Ltd. addressed to non-registered shareholders regarding the arrangement of electronic dissemination of corporate communications. It explains the company's adoption of electronic delivery of various corporate documents such as directors' reports, annual accounts, auditors' reports, interim reports, notices of meetings, listing documents, circulars, and proxy forms. The letter also includes instructions for shareholders on how to receive these communications electronically or in printed form, and contains a reply form for shareholders to request printed copies. There is no actual financial data, financial statements, or detailed report content included. The document is essentially an announcement about the method of distribution of corporate communications rather than the communications themselves or any financial or management report. It also references regulatory rules (Listing Rules Rule 2.07A) related to electronic dissemination. Given the nature of the document as an announcement about the publication and distribution of reports and communications, and its relatively short length (13,607 characters), it fits the criteria for a Report Publication Announcement (RPA) rather than an Annual Report (10-K), Interim Report (IR), or other substantive report types.
2024-02-08 English
Notification Letter and Reply Form to Registered Shareholders-Arrangement of Electronic Dissemination of Corporate Communications
Report Publication Announcement Classification · 95% confidence The document is a letter dated 8 February 2024 from Sinopharm Group Co. Ltd. addressed to shareholders regarding the arrangement of electronic dissemination of corporate communications. It explains the adoption of electronic delivery of various corporate documents such as directors' reports, annual accounts, interim reports, notices of meetings, listing documents, circulars, and proxy forms. It also includes a reply form for shareholders to provide their email addresses or request printed copies. The document does not contain any financial statements, audit opinions, management discussions, or voting results. It is an announcement about how future reports and communications will be distributed electronically rather than a report itself. The document length is about 13,542 characters, but it is primarily informational and procedural, not a financial or regulatory report. Therefore, it fits the category of Report Publication Announcement (RPA), which covers announcements regarding the timing, release, or publication of company reports or communications.
2024-02-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
Regulatory Filings Classification · 95% confidence The document is a monthly return report submitted to the Hong Kong Exchanges and Clearing Limited regarding movements in securities, specifically detailing movements in authorised/registered share capital and issued shares for Sinopharm Group Co. Ltd. It includes confirmations related to securities issuance and compliance with listing rules. The document is structured as a regulatory submission with detailed share capital and share movement data but does not contain financial statements, earnings data, or management discussion. It is not an announcement of a report publication but a regulatory filing itself. The content fits the category of a regulatory announcement related to share capital and securities movements, which aligns with the 'Regulatory Filings' category as a general regulatory announcement that does not fit more specific categories like share issue or director dealings. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-02-02 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.